Concerning barrier function, there is strong impairment of TJ barrier in lesional and no impairment in AD non-lesional skin with no or only mild downregulation of claudin-1 [74], reflecting the dose dependency of TJ barrier function on claudin-1 levels [74,78]. Here, CLDN1 is linked to Alzheimer disease.